Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer

Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer

Objective: N6-methyladenosine (m6A) modification may modulate various biological processes. Nonetheless, clinical implications of m6A modification in pancreatic cancer are undefined. Herein, this study comprehensively characterized the m6A modification patterns in pancreatic cancer based on m6A regu...

Full description

Bibliographic Details
Main Authors:	Kun Fang, Hairong Qu, Jiapei Wang, Desheng Tang, Changsheng Yan, Jiamin Ma, Lei Gao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Genetics
Subjects:	pancreatic cancer N6-methyladenosine regulators prognosis immune microenvironment immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.702072/full

Similar Items

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
by: Yong Liu, et al.
Published: (2022-01-01)

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer
by: Yongdong Guo, et al.
Published: (2021-11-01)

Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma
by: Jian Ji, et al.
Published: (2023-08-01)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
by: Liting Guo, et al.
Published: (2021-12-01)

Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer
by: Yihong Luo, et al.
Published: (2022-01-01)

m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma
by: Jianhao Li, et al.
Published: (2021-07-01)

M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma
by: Guangyu Xu, et al.
Published: (2023-02-01)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
by: Kun Zhao, et al.
Published: (2022-11-01)

Role of m6A modification in immune microenvironment of digestive system tumors
by: Chao Li, et al.
Published: (2023-08-01)

Integrated Analyses of m<sup>6</sup>A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pan-Cancer
by: Qingkang Cao, et al.
Published: (2022-09-01)

m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer
by: Mengyu Sun, et al.
Published: (2021-09-01)

m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment
by: Wenyi Zhang, et al.
Published: (2022-04-01)

Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
by: Jiahua Chen, et al.
Published: (2022-11-01)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
by: Zhang Meijing, et al.
Published: (2022-06-01)

Links Between N6-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
by: Yundi Zhang, et al.
Published: (2022-02-01)

Targeting the RNA m6A modification for cancer immunotherapy
by: Xinxin Li, et al.
Published: (2022-03-01)

m6A Regulator-Mediated RNA Methylation Modification Patterns are Involved in the Pathogenesis and Immune Microenvironment of Depression
by: Ye Wang, et al.
Published: (2022-04-01)

N6-Methyladenosine Regulator-Mediated Methylation Modification Patterns with Distinct Prognosis, Oxidative Stress, and Tumor Microenvironment in Renal Cell Carcinoma
by: Chunyang Li, et al.
Published: (2024-01-01)

Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment
by: Peng-Wei Cao, et al.
Published: (2022-04-01)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
by: Bo Chen, et al.
Published: (2021-11-01)

STM2457 Inhibits the Invasion and Metastasis of Pancreatic Cancer by Down-Regulating BRAF-Activated Noncoding RNA N6-Methyladenosine Modification
by: Shaolong Hao, et al.
Published: (2023-11-01)

m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-07-01)

m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer
by: Liangliang Cai, et al.
Published: (2023-12-01)

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
by: Chin-King Looi, et al.
Published: (2019-04-01)

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma
by: Liting Lu, et al.
Published: (2022-09-01)

Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer
by: Wenzhe Gao, et al.
Published: (2022-12-01)

The potential role of m6A modifications on immune cells and immunotherapy
by: Linchuan Gan, et al.
Published: (2023-04-01)

Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses
by: Kun Fang, et al.
Published: (2022-05-01)

A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma
by: Kai Zhao, et al.
Published: (2022-07-01)

Pancreatic Cancer and Microenvironments: Implications of Anesthesia
by: Hou-Chuan Lai, et al.
Published: (2022-05-01)

Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy
by: Xinke Zhang, et al.
Published: (2022-01-01)

Association between autophagy and acute pancreatitis
by: Tao Zhang, et al.
Published: (2023-01-01)

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
by: Meng-Meng Zhang, et al.
Published: (2021-12-01)

Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m6A Regulators in Early-Stage Lung Adenocarcinoma
by: Bolun Zhou, et al.
Published: (2021-09-01)

Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients
by: Biao Zhang, et al.
Published: (2023-09-01)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
by: Guihua Tang, et al.
Published: (2023-06-01)

Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy
by: Ronglin Wang, et al.
Published: (2022-03-01)

N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
by: Chao Quan, et al.
Published: (2021-08-01)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
by: Rong Tang, et al.
Published: (2021-03-01)

Pancreatic cancer microenvironment: a current dilemma
by: Burak Uzunparmak, et al.
Published: (2019-01-01)